High-throughput methodologies, such as functional genomic screening and cell panel screening, play pivotal roles in deciphering the underlying genetic and molecular pathways involved in cancer etiology and drug resistance.
Here, we present how researchers can leverage functional genomic and cell panel screening to gain a more comprehensive understanding of biological processes and disease mechanisms, to support drug development efforts. Including examples how they're used in:
For research use only. Not for use in diagnostic procedures.
Overcoming hurdles in high-throughput profiling of cancer cell responses